Trump health officials plan to link coronavirus vaccines to the deaths of 25 children as they consider limiting which Americans should get the shots, according to four people familiar with the situation who spoke on the condition of anonymity to describe confidential information.
The findings appear to be based on information submitted to the federal Vaccine Adverse Event Reporting System, which contains unverified reports of side effects or bad experiences with vaccines submitted by anyone, including patients, doctors, pharmacists or even someone who sees a report on social media. The Centers for Disease Control and Prevention emphasizes that the database is not designed to assess whether a shot caused a death, a conclusion that requires thorough investigations by scientists and public health professionals.
Trump health officials plan to include the pediatric deaths claim in a presentation next week to an influential panel of advisers to the CDC that is considering new coronavirus vaccine recommendations, which affect access to the shots and whether they’re free.
The plan has alarmed some career scientists who say coronavirus vaccines have been extensively studied, including in children, and that dangers of the virus itself are being underplayed. While Trump health officials are investigating deaths due to vaccines, CDC staff in June presented data to the same vaccine committee showing that at least 25 children died who had COVID-associated hospitalizations since July 2023. That number, the staff said, was likely an undercount, and of the 16 old enough for vaccination, none was up-to-date on vaccines.
Food and Drug Administration Commissioner Marty Makary confirmed on CNN last week that officials were investigating reports of possible child deaths from the vaccine, including reviewing autopsy reports and interviewing families. Such a review could take months, according to health officials, and it is unclear when those investigations began.
The pediatric deaths presentation to the CDC’s Advisory Committee on Immunization Practices (ACIP) is not final, according to one person familiar with the matter, who spoke on the condition of anonymity to describe ongoing policy discussions. The full methodology for the analysis was not immediately clear.
“FDA and CDC staff routinely analyze VAERS and other safety monitoring data, and those reviews are being shared publicly through the established ACIP process,” HHS spokesperson Andrew Nixon said in an email. “Any recommendations on updated COVID-19 vaccines will be based on gold standard science and deliberated transparently at ACIP next week.”
The FDA in August approved the latest coronavirus vaccines for people ages 65 and older or who have risk factors for severe disease, but the CDC vaccine panel can recommend the shots more narrowly or broadly. The committee is weighing a plan to recommend the shot for those 75 and older but instruct people who are younger to speak to a physician before they get the vaccine, according to two people familiar with the matter who spoke on the condition of anonymity to share policy discussions. Another option would not recommend the vaccine to people under the age of 75 without preexisting conditions, the people said.